Publications

Kerns WD, et al. Drug-Induced vascular injury—A quest for biomarkers. Toxicol Appl Pharmacol: 203 (1): 62-87, 2005.
Kerns WD, et al. Idiopathic Canine Polyarteritis. In:Patholobiology of the Aging Dog, Mohr U, Carlton WW, Dungworth DL, Benjamin SA, Capen CA, Hahn FF (eds.). Vol. 2, pp. 118-126, Iowa State University Press, Ames, 2001.
Fong, Kei-Lai et al. Preclinical evaluation of Hematide, a novel erythropoiesis stimulating agent, for the treatment of anemia. Experimental Hematology, Volume 34, Issue 10, Pages 1303-1311 Q.
Michael H. Silverman...William D. Kerns...and Pnina Fishmman, Clinical Evidence for Utilization of A3 Adenosine Receptor as a Target to Treat Rheumatoid Arthritis: Data from a Phase II Clinical Trial, The Journal of Rheumatology 2008: 35:1. Click here to view
Peter Gaskin, et al., Tyrosinemia produced by 2-(2-nitro-4-triflouromethylbenzoyl)-cyclohexane -1,3-dione (NTBC) in experimental animals and its relationship to corneal injury Toxicol Appl Pharmacol. 2006
Kathryn W. Woodburn…Kei-lai Fong et.al. Preclinical Safety and Pharmacology of Hematide™, a Peptidic Erythropoiesis Stimulating Agent (ESA), in Rats and Monkeys, Drug and Chemical Toxicology, Volume 31, Issue 2 April 2008 , pages 229 – 244. Click here to view abstract.
Kathryn W. Woodburn…Kei-lai Fong et.al., Chronic preclinical safety evaluation of Hematide™, a pegylated peptidic erythropoiesis stimulating agent in monkeys, Haematologica/The Hematology Journal, June 2008, pages 120 – 123. Click to view article in pdf format or online